|
|
Charak: Hyponidd |
||
|
|
||
| Prijs:
€6,95
|
Aantal (eenheden) in verpakking:20 |
|
Hyponidd Tablets (Charak) Suggested Usage: 2 tablets twice a day, half an-hour before meals for IGT, IFG and PCOS. Ingredient List: Yashad Bhasma 37.5 mg Shilajit (Purified asphaltum) 37.5 mg Karavellaka/Karela (Momordica charantia) 12 mg Extracts derived from Haridra (Curcuma longa) 300 mg Tarwar (Cassia auriculata) 225 mg Amalaki (Emblica officinalis) 150 mg Raja Jambu/Jamun (Eugenia jambolana) 150 mg Mamejavo (Enicostemma littorale) 112.5 mg Meshashringi (Gymnema sylvestre) 112.5 mg Vijaysaar (Pterocarpus marsupium) 75 mg Guduchi (Tinospora cordifolia) 75 mg Neem (Melia azadirachta) 75 mg Kirat Tikta (Swertia chirata) 12 mg THERAPEUTIC RATIONALE (For PCOS): Polycystic Ovarian Syndrome (PCOS) affects 6-10 % of women population and it is very often associated with insulin resistance. PCOS leads to amneorrhoea, anovulation, oligomenorrhoea, hirsutism etc. HYPONIDD in PCOS improves ovulatory function and several metabolic derangements associated with insulin resistance. HYPONIDD decreases the insulin resistance and thereby corrects the three axes namely metabolic, reproductive and steroidogenic. Flavonoid constituents of Pterocarpus marsupium like marsupin, pterosupin and epicatechin are insulinogenic because of post-receptor intracellular mediation by d-chiro-inositol. HYPONIDD thus, is safe and effective insulin sensitizer for the treatment of PCOS. THERAPEUTIC RATIONALE (For diabetes): HYPONIDD is a combination of herbs and minerals for diabetes treatment. The ingredients are proven to have a definite beneficial effect not only in lowering blood sugar levels but also in lipid lowering effect. The cumulative pharmacological action of HYPONIDD is insulin sensitizing, antihyperglycemic, hypolipidemic and antioxidant. HYPONIDD minimizes the chances of diabetic complications, if started sufficiently early. Indications In PCOS associated with adolescent infertile women on oral contraceptive pills: As insulin sensitizer. Long-term management of PCOD. Adjuvant to OHA, or a stand alone in newly detected cases of mild diabetes mellitus. Recommended Dosage: In Polycystic Ovarian Syndrome (PCOS): recommended dose is 2 tablets twice daily for 3-6 months. In Diabetes: 2 tablets twice daily, half-an-hour before meals |
||
Beschikbaarheid Normaal verzonden na: ![]() |
||
Laatst geupdate op:










